➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: March 3, 2021

DrugPatentWatch Database Preview

FOLLISTIM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: FOLLISTIM

Patents:	9
Applicants:	1
BLAs:	3
Suppliers: see list	1
Drug Prices:	Drug price information for FOLLISTIM
Recent Clinical Trials:	See clinical trials for FOLLISTIM

Drug Prices for FOLLISTIM

See drug prices for FOLLISTIM

Recent Clinical Trials for FOLLISTIM

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Ferring Pharmaceuticals	Phase 2
Center for Human Reproduction	Phase 1/Phase 2
Michigan Reproductive Medicine	Phase 4

See all FOLLISTIM clinical trials

Company Disclosures: US Patents for FOLLISTIM

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211	001	2004-03-23	Start Trial	Genzyme Corporation (Cambridge, MA)	2015-06-16	DISCN		company
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211	001	2004-03-23	Start Trial	Akzo Nobel, N.V. (Arnhem, NL)	2017-01-15	DISCN		company
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211	001	2004-03-23	Start Trial	Ares Trading S.A. (Aubonne, CH)	2018-07-23	DISCN		company
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211	001	2004-03-23	Start Trial	Ares Trading S.A. (Aubonne, CH)	2018-07-23	DISCN		company
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211	002	2004-03-23	Start Trial	Genzyme Corporation (Cambridge, MA)	2015-06-16	DISCN		company
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211	002	2004-03-23	Start Trial	Akzo Nobel, N.V. (Arnhem, NL)	2017-01-15	DISCN		company
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211	002	2004-03-23	Start Trial	Ares Trading S.A. (Aubonne, CH)	2018-07-23	DISCN		company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for FOLLISTIM

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Organon Usa Inc	FOLLISTIM	follitropin alfa/beta	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020582	001	1998-11-18	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	DISCN		search
Organon Usa Inc	FOLLISTIM	follitropin alfa/beta	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020582	001	1998-11-18	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2029-05-13	DISCN		search
Organon Usa Inc	FOLLISTIM	follitropin alfa/beta	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020582	001	1998-11-18	Start Trial	Amylin Pharmaceuticals, Inc. (San Diego, CA)	2022-01-22	DISCN		search
Organon Usa Inc	FOLLISTIM	follitropin alfa/beta	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020582	001	1998-11-18	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	DISCN		search
Organon Usa Inc	FOLLISTIM	follitropin alfa/beta	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020582	001	1998-11-18	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2029-05-13	DISCN		search
Organon Usa Inc	FOLLISTIM	follitropin alfa/beta	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020582	002	1998-11-18	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2033-03-11	DISCN		search
Organon Usa Inc	FOLLISTIM	follitropin alfa/beta	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020582	002	1998-11-18	Start Trial	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	2029-05-13	DISCN		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for FOLLISTIM

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Spain	2372481	Start Trial
Australia	2003256988	Start Trial
Austria	522226	Start Trial
European Patent Office	1523325	Start Trial
World Intellectual Property Organization (WIPO)	2004052390	Start Trial
Japan	2005526712	Start Trial
Denmark	1523325	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Dow

Express Scripts

Harvard Business School

Merck

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.